Newton, MA August 31, 2009. Harvard Pilgrim Health Care and MedMinder Systems, Inc., will be collaborating to study the use of MedMinder services in a population of patients with chronic illness. The randomized controlled study, which begins in early September, is focused on assessing the impact of the MedMinder system in a population of patients with chronic kidney disease (CKD) who must take multiple medications.
MedMinder provides a comprehensive medication adherence solution that helps patients take the right medicine at the right time, and allows care managers and family members to monitor the patient’s medication activity. The MedMinder solution includes the Maya unit, an intelligent pill dispenser equipped with wireless technology, and the feature-rich, configurable MedMinder web application. Monitoring patients’ behavior, MedMinder provides real time notifications and reminders to patients, families and care managers. The detailed adherence data collected by the system is accessible via the MedMinder web application and can be integrated with other clinical systems such as predictive modeling, case management and electronic medical records.
Approximately 26 million Americans have CKD. There currently is no cure for this disease, but it is possible to slow disease progression and treat CKD complications through appropriate medication use. In spite of the known benefits to taking medications as prescribed, consistent use of multiple medications can be a challenge for persons with CKD. Supporting successful medication management is critical in slowing disease progression to kidney failure, a condition that requires dialysis or kidney transplant.
“Medication adherence is critical to successful treatment outcomes, especially with chronically ill patients,” said Lydia Bernstein, Director, Clinical Quality Initiatives at Harvard Pilgrim Health Care. “We are always looking for ways to help patients and their families better cope with their illnesses and complex treatment regimens. The findings from the evaluation of MedMinder’s Maya system will help us better understand the potential and suitability of this innovative adherence solution.”
“We are excited by this unique opportunity to work with Harvard Pilgrim to participate in scientific research that seeks to improve the medication use of persons with chronic kidney disease.” said Eran Shavelsky, CEO of MedMinder Systems. “At MedMinder, we believe a more comprehensive solution is needed to help patients consistently take the right pills at the right time. We also have seen that family members need and want to be involved with their loved one’s care. With the Maya pill dispenser, we are providing them with real-time notifications in the event of a missed-dose, overdose, missed refill, etc.”
MedMinder Systems Inc., a Massachusetts based company, provides services that simplify medication management and improve medication adherence. For more information, please visit www.medminder.com.
Harvard Pilgrim is a not-for-profit health plan that provides a variety of health benefit options and funding arrangements to more than one million members in Massachusetts, New Hampshire and Maine. For more information, please visit www.harvardpilgrim.org.
Harvard Pilgrim has been named the #1 commercial health plan in the nation for four straight years by the U.S. News & World Report’s annual national survey of health plan performance*, and was recently identified as having the highest member satisfaction among commercial health plans in the New England Region in the J.D. Power and Associates 2009 National Health Insurance Plan Study**.*America’s Best Health Plans is a trademark of U.S.News & World Report. The source for this data is Quality Compass® and is used with the permission of the National Committee for Quality Assurance (NCQA). Quality Compass is a registered trademark of NCQA. NCQA is a private, non-profit organization dedicated to improving health care quality. ** Harvard Pilgrim Health Care received the highest numerical score among large commercial health plans in the New England region in the proprietary J.D. Power and Associates 2009 National Health Insurance Plan StudySM. Study based on 33,007 total member responses, measuring 12 plans in the New England region (CT, MA, ME, NH, RI, VT) (excludes Medicare and Medicaid). Proprietary study results are based on experiences and perceptions of members surveyed in December 2008 and January 2009. Your experiences may vary. jdpower.com.